Skip to main content
. 2023 Feb 16;11:1052942. doi: 10.3389/fcell.2023.1052942

TABLE 1.

LncRNAs involved in TIME of GC disease.

LncRNA Expression Pathway References
LINC00001 Upregulated in GC tissuses miR-497/MACC1 axis Ma et al. (2017)
LINC00008 Upregulated in GC tissuses miR-138/E2F2 axis Yu et al. (2020)
LINC00023 Downregulated in GC tissuses p53 signaling pathway Wei and Wang (2017)
LINC00047 Upregulated in GC tissuses PI3K/AKT pathway Zhu et al. (2019)
LINC00152 Upregulated in GC tissuses EGFR-dependent pathway Zhou et al. (2015)
LINC00256A Upregulated in GC tissuses FAM225A-miR-206-ADAM12 axis Chen et al. (2021)
LINC00342 Upregulated in GC tissuses miR-545-5p/CNPY2 axis Liu and Yang (2021)
LINC00902 Downregulated in GC tissuses p53 and mIR-23b Qi et al. (2015)
LINC01082 Upregulated in GC tissuses suppressed GC cells and PD-L1 Wang et al. (2022f)
LINC01540 Upregulated in GC tissuses miR-378 to modulate MAPK1 expression Diao et al. (2018)
LINC-POU3F3 Upregulated in GC tissuses TGF-beta signal pathway Xiong et al. (2015)
HIF1A-AS2 Upregulated in GC tissuses HIF1A-AS2/RP11-366L20.2-miR-29c axis Nai et al. (2022)

MACC1: metastasis-associated in colon cancer 1; E2F2: E2F transcription factor 2; PI3K: phosphatidylinositol 3-kinase; EGFR: epidermal growth factor receptor; ADAM12: A disintegrin and metalloprotease 12; CNPY2: canopy FGF signaling regulator 2; MAPK1: mitogen-activated protein kinase 1; TGF-beta: transforming growth factor-beta.